January 4, 2017 / 10:05 AM / in 7 months

BRIEF-Affimed, MD Anderson to collaborate on clinical immuno-oncology development

1 Min Read

Jan 4 (Reuters) - Affimed NV :

* Affimed and MD Anderson announce clinical immuno-oncology development collaboration

* Collaboration to evaluate Affimed's tandab technology in combination with MD Anderson's natural killer cell product Source text for Eikon: Further company coverage:

0 : 0
  • narrow-browser-and-phone
  • medium-browser-and-portrait-tablet
  • landscape-tablet
  • medium-wide-browser
  • wide-browser-and-larger
  • medium-browser-and-landscape-tablet
  • medium-wide-browser-and-larger
  • above-phone
  • portrait-tablet-and-above
  • above-portrait-tablet
  • landscape-tablet-and-above
  • landscape-tablet-and-medium-wide-browser
  • portrait-tablet-and-below
  • landscape-tablet-and-below